{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:09:39Z","timestamp":1790273379825,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB-1615550"],"award-info":[{"award-number":["MCB-1615550"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,1,23]]},"DOI":"10.1038\/s41388-019-1022-0","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T15:02:35Z","timestamp":1569250955000},"page":"723-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression"],"prefix":"10.1038","volume":"39","author":[{"given":"Tengyu","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"1022_CR1","first-page":"a003236","volume":"2","author":"EY Lee","year":"2010","unstructured":"Lee EY, Muller WJ. Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol. 2010;2:a003236.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1022_CR2","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.4161\/cc.9.14.12251","volume":"9","author":"R Bansal","year":"2010","unstructured":"Bansal R, Nikiforov MA. Pathways of oncogene-induced senescence in human melanocytic cells. Cell Cycle. 2010;9:2782\u20138.","journal-title":"Cell Cycle"},{"key":"1022_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/2159-8290.CD-17-1461","volume":"8","author":"P Kotsantis","year":"2018","unstructured":"Kotsantis P, Petermann E, Boulton SJ. Mechanisms of oncogene-induced replication stress: jigsaw falling into place. Cancer Discov. 2018;8:537\u201355.","journal-title":"Cancer Discov"},{"key":"1022_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/bse0390089","volume":"39","author":"M Labazi","year":"2003","unstructured":"Labazi M, Phillips AC. Oncogenes as regulators of apoptosis. Essays Biochem. 2003;39:89\u2013104.","journal-title":"Essays Biochem"},{"key":"1022_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432:307\u201315.","journal-title":"Nature"},{"key":"1022_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cellsig.2010.07.004","volume":"23","author":"FK McDuff","year":"2011","unstructured":"McDuff FK, Turner SD. Jailbreak: oncogene-induced senescence and its evasion. Cell Signal. 2011;23:6\u201313.","journal-title":"Cell Signal"},{"issue":"12","key":"1022_CR7","doi-asserted-by":"publisher","first-page":"a009829","DOI":"10.1101\/cshperspect.a009829","volume":"4","author":"J. Shortt","year":"2012","unstructured":"Shortt J, Johnstone RW. Oncogenes in cell survival and cell death. Cold Spring Harb Perspect Biol. 2012;4:a009829.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1022_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"1022_CR9","doi-asserted-by":"crossref","unstructured":"Hernandez B, Adissu HA, Wei BR, Michael HT, Merlino G, Simpson RM. Naturally occurring canine melanoma as a predictive comparative oncology model for human mucosal and other triple wild-type melanomas. Int J Mol Sci. 2018;19: pii: E394.","DOI":"10.3390\/ijms19020394"},{"key":"1022_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature09860","volume":"472","author":"DF Brennan","year":"2011","unstructured":"Brennan DF, Dar AC, Hertz NT, Chao WC, Burlingame AL, Shokat KM, et al. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK. Nature. 2011;472:366\u20139.","journal-title":"Nature"},{"issue":"24","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","volume":"37","author":"Matthew Dankner","year":"2018","unstructured":"Dankner M, Rose AAN, Rajkumar S, Siegel PM, Watson IR. Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations. Oncogene. 2018;3183\u201399.","journal-title":"Oncogene"},{"key":"1022_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"1022_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/mmt.15.38","volume":"3","author":"BY Kong","year":"2016","unstructured":"Kong BY, Carlino MS, Menzies AM. Biology and treatment of BRAF mutant metastatic melanoma. Melanoma Manag. 2016;3:33\u201345.","journal-title":"Melanoma Manag"},{"key":"1022_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436:720\u20134.","journal-title":"Nature"},{"key":"1022_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19\u201320.","journal-title":"Nat Genet"},{"key":"1022_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O\u2019Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008;133:1006\u201318.","journal-title":"Cell"},{"key":"1022_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133:1019\u201331.","journal-title":"Cell"},{"key":"1022_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.187252.112","volume":"26","author":"LC Vredeveld","year":"2012","unstructured":"Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012;26:1055\u201369.","journal-title":"Genes Dev"},{"key":"1022_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","volume":"95","author":"VC Gray-Schopfer","year":"2006","unstructured":"Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, et al. Cellular senescence in naevi and immortalisation in melanoma: a role forp16? Br J Cancer. 2006;95:496\u2013505.","journal-title":"Br J Cancer"},{"key":"1022_CR20","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1242\/jcs.115.11.2349","volume":"115","author":"MC Scott","year":"2002","unstructured":"Scott MC, Wakamatsu K, Ito S, Kadekaro AL, Kobayashi N, Groden J, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci. 2002;115:2349\u201355.","journal-title":"J Cell Sci"},{"key":"1022_CR21","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","volume":"89","author":"S Chellappan","year":"1992","unstructured":"Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, et al. Adenovirus-E1a, simian virus-40 tumor-antigen, and human papillomavirus-E7 Protein share the capacity to disrupt the interaction between transcription factor-E2f and the retinoblastoma gene-product. P Natl Acad Sci USA. 1992;89:4549\u201353.","journal-title":"P Natl Acad Sci USA"},{"key":"1022_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccr.2009.03.001","volume":"15","author":"A Shamma","year":"2009","unstructured":"Shamma A, Takegami Y, Miki T, Kitajima S, Noda M, Obara T, et al. Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell. 2009;15:255\u201369.","journal-title":"Cancer Cell"},{"key":"1022_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28:436\u201353.","journal-title":"Trends Cell Biol"},{"key":"1022_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783\u20134.","journal-title":"Nat Methods"},{"key":"1022_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"1022_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/acsmedchemlett.6b00014","volume":"7","author":"H Fukuda","year":"2016","unstructured":"Fukuda H, Ito S, Watari K, Mogi C, Arisawa M, Okajima F, et al. Identification of a potent and selective GPR4 antagonist as a drug lead for the treatment of myocardial infarction. ACS Med Chem Lett. 2016;7:493\u20137.","journal-title":"ACS Med Chem Lett"},{"key":"1022_CR27","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1042\/BCJ20170676","volume":"474","author":"B Dong","year":"2017","unstructured":"Dong B, Zhang X, Fan Y, Cao S, Zhang X. GPR4 knockout improves renal ischemia-reperfusion injury and inhibits apoptosis via suppressing the expression of CHOP. Biochem J. 2017;474:4065\u201374.","journal-title":"Biochem J"},{"key":"1022_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2011.08.013","volume":"312","author":"RD Castellone","year":"2011","unstructured":"Castellone RD, Leffler NR, Dong L, Yang LV. Inhibition of tumor cell migration and metastasis by the proton-sensing GPR4 receptor. Cancer Lett. 2011;312:197\u2013208.","journal-title":"Cancer Lett"},{"key":"1022_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/hep.1840090110","volume":"9","author":"CD Surh","year":"1989","unstructured":"Surh CD, Danner DJ, Ahmed A, Coppel RL, Mackay IR, Dickson ER, et al. Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen. Hepatology. 1989;9:63\u201368.","journal-title":"Hepatology"},{"key":"1022_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s100380050047","volume":"43","author":"M Tsuruta","year":"1998","unstructured":"Tsuruta M, Mitsubuchi H, Mardy S, Miura Y, Hayashida Y, Kinugasa A, et al. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex. J Hum Genet. 1998;43:91\u2013100.","journal-title":"J Hum Genet"},{"key":"1022_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1022_CR32","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19:A68\u201377.","journal-title":"Contemp Oncol"},{"key":"1022_CR33","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102.","journal-title":"Nucleic Acids Res"},{"key":"1022_CR34","doi-asserted-by":"crossref","unstructured":"Goldman M, Graft B, Hastie M, Repe\u010dka K, Kamath A, McDade F, et al. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. bioRxiv 2019.","DOI":"10.1101\/326470"},{"key":"1022_CR35","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/sj.onc.1206595","volume":"22","author":"VO Melnikova","year":"2003","unstructured":"Melnikova VO, Santamaria AB, Bolshakov SV, Ananthaswamy HN. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1\/2 MAP kinase. Oncogene. 2003;22:5958\u201366.","journal-title":"Oncogene"},{"key":"1022_CR36","doi-asserted-by":"publisher","first-page":"20444","DOI":"10.1074\/jbc.M001020200","volume":"275","author":"QB She","year":"2000","unstructured":"She QB, Chen NY, Dong ZG. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem. 2000;275:20444\u20139.","journal-title":"J Biol Chem"},{"key":"1022_CR37","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1038\/sj.onc.1204656","volume":"20","author":"D Xirodimas","year":"2001","unstructured":"Xirodimas D, Saville MK, Edling C, Lane DP, Lain S. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene. 2001;20:4972\u201383.","journal-title":"Oncogene"},{"key":"1022_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/25870","volume":"395","author":"I Palmero","year":"1998","unstructured":"Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 1998;395:125\u20136.","journal-title":"Nature"},{"key":"1022_CR39","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","volume":"12","author":"F Zindy","year":"1998","unstructured":"Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998;12:2424\u201333.","journal-title":"Genes Dev"},{"key":"1022_CR40","doi-asserted-by":"publisher","first-page":"21843","DOI":"10.1074\/jbc.M109745200","volume":"277","author":"Y Ogawara","year":"2002","unstructured":"Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 2002;277:21843\u201350.","journal-title":"J Biol Chem"},{"key":"1022_CR41","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","volume":"21","author":"TM Gottlieb","year":"2002","unstructured":"Gottlieb TM, Leal JF, Seger R, Taya Y, Oren M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene. 2002;21:1299\u2013303.","journal-title":"Oncogene"},{"key":"1022_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","volume":"23","author":"AG Georgakilas","year":"2017","unstructured":"Georgakilas AG, Martin OA, Bonner WM. p21: A two-faced genome guardian. Trends Mol Med. 2017;23:310\u20139.","journal-title":"Trends Mol Med"},{"key":"1022_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ncb3378","volume":"18","author":"P Galanos","year":"2016","unstructured":"Galanos P, Vougas K, Walter D, Polyzos A, Maya-Mendoza A, Haagensen EJ, et al. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat Cell Biol. 2016;18:777\u201389.","journal-title":"Nat Cell Biol"},{"key":"1022_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcdb.2016.01.009","volume":"50","author":"AM Kidger","year":"2016","unstructured":"Kidger AM, Keyse SM. The regulation of oncogenic Ras\/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs). Semin Cell Dev Biol. 2016;50:125\u201332.","journal-title":"Semin Cell Dev Biol"},{"key":"1022_CR45","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","volume":"73","author":"D Lake","year":"2016","unstructured":"Lake D, Correa SA, Muller J. Negative feedback regulation of the ERK1\/2 MAPK pathway. Cell Mol Life Sci. 2016;73:4397\u2013413.","journal-title":"Cell Mol Life Sci"},{"key":"1022_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-1923-9_12","volume-title":"Branched Chain Amino Acids in Clinical Nutrition","author":"Kevin Carpenter","year":"2015","unstructured":"Carpenter K. Branched chain amino acids and maple syrup urine disease. In: Rajendram R, Preedy VR, Patel V, editors. Branched chain amino acids in clinical nutrition, vol. 1. New York: Humana Press; 2015. p. 145\u201356."},{"key":"1022_CR47","doi-asserted-by":"crossref","unstructured":"Cole JT. Metabolism of BCAAa. In: Rajendram R, Preedy VR, Patel V, editors. Branched chain amino acids in clinical nutrition, vol. 1. New York: Humana Press; 2015. p. 13\u201324.","DOI":"10.1007\/978-1-4939-1923-9_2"},{"key":"1022_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","volume":"10","author":"PR Blackburn","year":"2017","unstructured":"Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57\u201366.","journal-title":"Appl Clin Genet"},{"key":"1022_CR49","doi-asserted-by":"crossref","unstructured":"Holecek M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab. 2018;15:33.","DOI":"10.1186\/s12986-018-0271-1"},{"key":"1022_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcell.2016.00033","volume":"4","author":"C Wellbrock","year":"2016","unstructured":"Wellbrock C, Arozarena I. The complexity of the ERK\/MAP-kinase pathway and the treatment of melanoma skin cancer. Front Cell Dev Biol. 2016;4:33.","journal-title":"Front Cell Dev Biol"},{"key":"1022_CR51","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/emboj\/cdg316","volume":"22","author":"MJ Caloca","year":"2003","unstructured":"Caloca MJ, Zugaza JL, Matallanas D, Crespo P, Bustelo XR. Vav mediates Ras stimulation by direct activation of the GDP\/GTP exchange factor Ras GRP1. EMBO J. 2003;22:3326\u201336.","journal-title":"EMBO J"},{"key":"1022_CR52","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.96.6.3035","volume":"96","author":"PS Costello","year":"1999","unstructured":"Costello PS, Walters AE, Mee PJ, Turner M, Reynolds LF, Prisco A, et al. TheRho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappa B pathways. P Natl Acad Sci USA. 1999;96:3035\u201340.","journal-title":"P Natl Acad Sci USA"},{"key":"1022_CR53","doi-asserted-by":"publisher","first-page":"18239","DOI":"10.1074\/jbc.M400257200","volume":"279","author":"LF Reynolds","year":"2004","unstructured":"Reynolds LF, de Bettignies C, Norton T, Beeser A, Chernoff J, Tybulewicz VL. Vav1 transduces T cell receptor signals to the activation of the Ras\/ERK pathway via LAT, Sos, and RasGRP1. J Biol Chem. 2004;279:18239\u201346.","journal-title":"J Biol Chem"},{"key":"1022_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-4-5","volume":"4","author":"JL Wilsbacher","year":"2006","unstructured":"Wilsbacher JL, Moores SL, Brugge JS. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand. Cell Commun Signal. 2006;4:5.","journal-title":"Cell Commun Signal"},{"key":"1022_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1101\/gad.203984.112","volume":"27","author":"X Deschenes-Simard","year":"2013","unstructured":"Deschenes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, et al. Tumor suppressor activity of the ERK\/MAPK pathway by promoting selective protein degradation. Genes Dev. 2013;27:900\u201315.","journal-title":"Genes Dev"},{"key":"1022_CR56","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1038\/sj.onc.1207838","volume":"23","author":"WC Sin","year":"2004","unstructured":"Sin WC, Zhang Y, Zhong W, Adhikarakunnathu S, Powers S, Hoey T, et al. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene. 2004;23:6299\u2013303.","journal-title":"Oncogene"},{"key":"1022_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10456-011-9238-9","volume":"14","author":"L Wyder","year":"2011","unstructured":"Wyder L, Suply T, Ricoux B, Billy E, Schnell C, Baumgarten BU, et al. Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor. Angiogenesis. 2011;14:533\u201344.","journal-title":"Angiogenesis"},{"issue":"2","key":"1022_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/ijms18020278","volume":"18","author":"Lixue Dong","year":"2017","unstructured":"Dong L, Krewson EA, Yang LV. Acidosis activates endoplasmic reticulum stress pathways through gpr4 in human vascular endothelial cells. Int J Mol Sci. 2017;18:278.","journal-title":"International Journal of Molecular Sciences"},{"key":"1022_CR59","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/bi035051y","volume":"42","author":"M Bektas","year":"2003","unstructured":"Bektas M, Barak LS, Jolly PS, Liu H, Lynch KR, Lacana E, et al. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. Biochemistry. 2003;42:12181\u201391.","journal-title":"Biochemistry"},{"key":"1022_CR60","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.277.5327.831","volume":"277","author":"JP Brown","year":"1997","unstructured":"Brown JP, Wei WY, Sedivy JM. Bypass of senescence after disruption ofp21(CIP1\/WAF1) gene in normal diploid human fibroblasts. Science. 1997;277:831\u20134.","journal-title":"Science"},{"key":"1022_CR61","first-page":"71","volume":"908","author":"D Bandyopadhyay","year":"2000","unstructured":"Bandyopadhyay D, Medrano EE. Melanin accumulation accelerates melanocyte senescence by a mechanism involvingp16(INK4a)\/CDK4\/pRB and E2F1. Mol Cell Gerontol. 2000;908:71\u201384.","journal-title":"Mol Cell Gerontol"},{"key":"1022_CR62","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1038\/sj.onc.1210411","volume":"26","author":"DN Dhanasekaran","year":"2007","unstructured":"Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene. 2007;26:3185\u2013202.","journal-title":"Oncogene"},{"key":"1022_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.15252\/embr.201439834","volume":"16","author":"AC Hedman","year":"2015","unstructured":"Hedman AC, Smith JM, Sacks DB. The biology of IQGAP proteins: beyond the cytoskeleton. Embo Rep. 2015;16:427\u201346.","journal-title":"Embo Rep"},{"key":"1022_CR64","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.2147\/OTT.S182721","volume":"11","author":"S Kakadia","year":"2018","unstructured":"Kakadia S, Yarlagadda N, Awad R, Kundranda M, Niu JX, Naraev B, et al. Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma. Oncotargets Ther. 2018;11:7095\u2013107.","journal-title":"Oncotargets Ther"},{"issue":"1","key":"1022_CR65","doi-asserted-by":"publisher","first-page":"pdb.prot3871","DOI":"10.1101\/pdb.prot3871","volume":"2006","author":"Joseph Sambrook","year":"2006","unstructured":"Sambrook J, Russell DW. Calcium-phosphate-mediated transfection of eukaryotic cells with plasmid DNAs. CSH Protoc. 2006;2006: pii: pdb.prot3871.","journal-title":"Cold Spring Harbor Protocols"},{"key":"1022_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, Koster J, Xu H, Chen CH, Xiao T, Liu JS, et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 2015;16:281.","journal-title":"Genome Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1022-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:11:12Z","timestamp":1650100272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1,23]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-1022-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}